Combining Epigenetic And Immune Therapy to Beat Cancer.
Clinical trial NCT04705818 · COMPLETED
Trial details
- NCT number
- NCT04705818
- Sponsor
- Institut Bergonié
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-23
- Primary completion
- 2024-01-07
- Enrollment
- 164
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.